Provided by Tiger Fintech (Singapore) Pte. Ltd.

Allogene Therapeutics Inc.

1.42
+0.130010.08%
Post-market: 1.430.0100+0.70%19:25 EDT
Volume:3.48M
Turnover:4.93M
Market Cap:310.60M
PE:-1.16
High:1.47
Open:1.30
Low:1.29
Close:1.29
Loading ...

Allogene Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

BRIEF-Allogene Therapeutics Inc QTRLY Loss Per Share $0.28

Reuters
·
14 May

Allogene Therapeutics: Guidance 2025 Is Expected Decrease in Cash, Cash Equivalents, Investments of About $150 Mln

THOMSON REUTERS
·
14 May

Allogene Therapeutics Inc: Qtrly Loss per Share $0.28

THOMSON REUTERS
·
14 May

BRIEF-Allogene Therapeutics Reports First Quarter 2025 Financial Results And Business Update

Reuters
·
14 May

Allogene Therapeutics Reports Q1 2025 Net Loss of $59.7M with EPS of $0.28, Cash and Investments Total $335.5M

Reuters
·
14 May

Allogene Therapeutics Q1 EPS $(0.28) Beats $(0.29) Estimate

Benzinga
·
14 May

Allogene Therapeutics Inc: Cash Runway Into 2H 2027

THOMSON REUTERS
·
14 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
13 May

Allogene Therapeutics Inc expected to post a loss of 29 cents a share - Earnings Preview

Reuters
·
10 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
30 Apr

Allogene Therapeutics, Inc. (NASDAQ:ALLO) is a favorite amongst institutional investors who own 59%

Simply Wall St.
·
25 Apr

Allogene Therapeutics to present updated ALLO-316 results at ASCO meeting

TIPRANKS
·
23 Apr

William Blair Reaffirms Their Buy Rating on Allogene Therapeutics (ALLO)

TIPRANKS
·
21 Apr

William Blair Reaffirms Their Buy Rating on Allogene Therapeutics (ALLO)

TIPRANKS
·
10 Apr

FDA Grants Three Fast Track Tags to Allogene's Autoimmune Disease Drug

Zacks
·
08 Apr

Allogene Gets FDA Fast Track Designations for ALLO-329 in Autoimmune Diseases

MT Newswires Live
·
07 Apr

BRIEF-Allogene Granted Three U.S. FDA Fast Track Designations (Ftd) For Allo-329

Reuters
·
07 Apr

Allogene Therapeutics granted three Fast Track Designations for ALLO-329

TIPRANKS
·
07 Apr

Allogene Therapeutics Shares up 2.8% Premarket After Co Granted Three FDA Fast Track Designations for Allo-329

THOMSON REUTERS
·
07 Apr